A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study.
Runze WenMin ZhaoChang ChenYi YangBin ZhangPublished in: Endocrine (2023)
We proposed a new nomogram to predict non-ER for DTC with excellent discrimination and calibration.